Quarterly report [Sections 13 or 15(d)]

Divestitures - Key Components of Net Income (Loss) from Discontinued Operations (Details)

v3.25.3
Divestitures - Key Components of Net Income (Loss) from Discontinued Operations (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Cost of revenues:        
Income (loss) before income tax expense $ 664,269 $ (2,693,562) $ 3,424,697 $ (2,896,541)
Income tax expense from discontinued operations 99,630 57,194 303,243 394,692
Net income (loss) from discontinued operations 564,639 (2,750,756) 3,121,454 (3,291,233)
Corporate Clinics        
Cost of revenues:        
Income tax expense from discontinued operations 99,630 57,194 303,243 394,692
Net income (loss) from discontinued operations 564,639 (2,750,756) 3,121,454 (3,291,233)
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics        
Revenues:        
Total revenues 10,520,596 17,544,094 44,068,960 52,732,070
Cost of revenues:        
Total cost of revenues 4,181 8,304 15,906 34,150
Selling and marketing expenses 1,012,959 2,258,227 4,731,358 5,868,201
Depreciation and amortization 16,310 893,398 59,815 3,149,029
General and administrative expenses 7,942,168 13,275,594 32,070,385 40,977,423
Total selling, general and administrative expenses 8,971,437 16,427,219 36,861,558 49,994,653
Total net loss on disposition or impairment related to discontinued operations 860,598 3,801,637 3,746,449 5,598,123
Income (loss) from discontinued operations 684,380 (2,693,066) 3,445,047 (2,894,856)
Other expense, net 20,111 496 20,350 1,685
Income (loss) before income tax expense $ 664,269 $ (2,693,562) $ 3,424,697 $ (2,896,541)